AAP
THRD

Arax Advisory Partners’s Third Harmonic Bio THRD Stock Holding History

Arax Advisory Partners’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-171
Closed -$1.76K – 3034
2024
Q4 		$1.76K Hold
171
– – ﹤0.01% 2036
2024
Q3 		$2.32K Hold
171
– – ﹤0.01% 2012
2024
Q2 		$2.22K Buy
+171
New +$2.12K ﹤0.01% 1928

Other funds holding THRD

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Arax Advisory Partners's THRD Position: Q1 2025 in Review

Arax Advisory Partners sold out of Third Harmonic Bio (THRD) in Q1 2025, closing a stake of 171 shares — an estimated $1.76K sold.

Arax Advisory Partners first reported a position in THRD in Q2 2024 and held it in 3 quarters. The position peaked at $2.32K in Q3 2024. 99 funds tracked by Wall St. Rank hold THRD as of Q1 2025.

  • Arax Advisory Partners reported no remaining Third Harmonic Bio position as of Q1 2025 after selling out during the quarter.
  • Arax Advisory Partners sold 171 Third Harmonic Bio shares in Q1 2025, an estimated $1.76K.
  • Arax Advisory Partners first reported a position in Third Harmonic Bio in Q2 2024 and held it in 3 quarters.
  • Arax Advisory Partners's Third Harmonic Bio position peaked at $2.32K in Q3 2024.
  • 99 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q1 2025.

Based on Arax Advisory Partners's 13F filing for Q1 2025, filed 15 May 2025.